NCT02986503View on ClinicalTrials.gov

European Study in Bone Sarcoma Patients Over 40 Years

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

December 31, 2015

Study Completion Date

November 30, 2016

Conditions
Spindle Cell Sarcoma of BoneOsteosarcoma
Interventions
DRUG

Doxorubicin+cisplatin+ifosfamide

Chemotherapy for Good responder high grade osteosarcoma

DRUG

Doxorubicin+cisplatin+ifosfamide+methotrexate

Chemotherapy for Poor responder high grade osteosarcoma

Trial Locations (3)

40136

Istituti Ortopedici Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors, Bologna

D-70176

Cooperative Osteosarcoma Study Group, Stuttgart

SE-221 85

Scandinavian Sarcoma Group, Lund

All Listed Sponsors
collaborator

Scandinavian Sarcoma Group

OTHER

collaborator

Cooperative Osteosarcoma Study Group

UNKNOWN

lead

Italian Sarcoma Group

NETWORK

NCT02986503 - European Study in Bone Sarcoma Patients Over 40 Years | Biotech Hunter | Biotech Hunter